HOW PHARMA IS REVAMPING THEIR APPROACH TO CUSTOMER ENGAGEMENT AS A RESULT OF COVID-19

Solomon Page brought together pharmaceutical and biotech leaders to discuss new models of engagement—both externally and internally—as a result of COVID-19. The conversation, chaired by Luigi Frezza, featured current and future digital transformation strategies, challenges experienced to date, and key findings of this evolution.

KEY TAKEAWAYS:

• State of Digital Adoption: How pharmaceutical companies are adapting to the digital evolution and the impact on the employee population
  
• Models of Engagement: How pharma is taking a new approach to customer engagement  
  
• Digital Marketing: The current and future state of digital marketing within organizations